News
Home>News & Events>Publications>C-Path>Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
86,41
Related Posts
-
Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
-
Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
-
Qualitative development and content validity of the non–small cell lung cancer symptom assessment questionnaire (NSCLC-SAQ), A patient-reported outcome instrument
-
Interpreting change in scores on clinical outcome assessments
-
Patient-Reported Outcomes In Clinical Trials Of CKD-Related Therapies: Report Of A Symposium Sponsored By The National Kidney Foundation And The US Food And Drug Administration